Tag Archives: CHMA

stock market indicators

According to NVIDIA(NASDAQ:NVDA) CEO Jen-Hsun Huang, there are about 1 billion PCs around the world that aren’t “game-ready.” A PC that is not game-ready usually has an older graphics processing unit (GPU) or an integrated GPU. An integrated GPU is a central processing unit (CPU) that has its own built-in graphics capability, and these are less powerful than a stand-alone GPU.

NVIDIA has recently tried to bring these non-game-ready PC owners in to the gaming fold with its PC revival kit. These kits provided everything needed to upgrade an out-of-date PC to power the latest games.

The PC revival kit and NVIDIA’s game streaming service, GeForce NOW, target the millions of potential PC gamers who play infrequently, or haven’t played PC games at all. In order to get the most out of new blockbuster games, a PC needs to be equipped with a powerful GPU, such as NVIDIA’s GeForce GTX 1060 or GTX 1080.

stock market indicators: Chiasma, Inc.(CHMA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Chiasma Inc (NASDAQ: CHMA) was down, falling around 13 percent to $9.51 ahead of the U.S. Food and Drug Administration’s decision on Friday to approve or reject the company’s therapy. The status of its oral treatment for acromegaly, a capsule known as Mycapssa, will be in focus on Friday. The Street’s biotechnology expert Adam Feuerstein stated that an investor source believes the FDA will reject Chiasma’s capsules because data from a single-arm study failed to demonstrate a clinically meaningful benefit among patients.

stock market indicators: Two Harbors Investments Corp(TWO)

Advisors’ Opinion:

  • [By David Hanson]

    This week at the Barclays Capital Global Financials Conference, droves of CEOs, CFOs, and CIOs trotted on stage to address a room full of eager analysts. One of the lone mREITs represented was Two Harbors (NYSE: TWO  ) . CEO Tom Siering and CIO Bill Roth weighed in on the current environment.

stock market indicators: Flowers Foods, Inc.(FLO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Dr Pepper Snapple Group Inc. (NYSE: DPS) to report quarterly earnings at $1.06 per share on revenue of $1.57 billion before the opening bell. Dr Pepper Snapple shares fell 0.07 percent to close at $93.49 on Monday.
    Analysts expect American International Group Inc (NYSE: AIG) to post quarterly earnings at $1.01 per share on revenue of $12.87 billion after the closing bell. AIG shares gained 0.38 percent to $66.39 in after-hours trading.
    Flowers Foods, Inc. (NYSE: FLO) reported in-line earnings for its fourth quarter, while sales missed expectations. Flowers Foods shares fell 1.87 percent to $20.45 in the after-hours trading session.
    Before the markets open, Diebold Nixdorf Inc (NYSE: DBD) is projected to report its quarterly earnings at $0.32 per share on revenue of $1.31 billion. Diebold Nixdorf shares slipped 0.73 percent to close at $27.20 on Monday.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Dan Caplinger]

    Consumers across the nation know Flowers Foods (NYSE:FLO) from its Wonder bread, Tastykake snack cakes, and Nature’s Own bakery brands. Yet the truly novel thing about Flowers is how it has done such a good job of building up a national presence in an industry that is typically dominated by local competition. Coming into Monday’s fourth-quarter financial report, Flowers investors were hoping to see at least some growth in sales and earnings, but the bakery company wasn’t able to deliver the pace of expansion that most shareholders really want to see.

stock market indicators: Tucows Inc.(TCX)

Advisors’ Opinion:

  • [By Anders Bylund]

    Shares of Tucows (NASDAQ:TCX) rose 12.1% in March 2017, according to data from S&P Global Market Intelligence.

    So what

    The provider of online business services and a budding bundle of mobile and fiber-optic communications products started March with a bang, announcing a brand-new $40 million share buyback program. For a company with a $476 million market cap at the time, that’s a pretty serious and shareholder-friendly commitment.

  • [By Lisa Levin]

    Tucows Inc. (USA) (NASDAQ: TCX) shares shot up 17 percent to $42.45 after the company announced plans to acquire eNom from Rightside for $83.5 million.

stock market indicators: Ingles Markets Incorporated(IMKTA)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Not all grocers will suffer from Amazon’s growing reach, but those who sell to high-income customers in the top 25 U.S. markets may see their business erode. Among those names include Costco (COST) , Trader Joe’s and Whole Foods (WFM) , which have the most to lose according to Barclays. On the other hand, Walmart (WMT) , Sam’s Club (owned by Walmart) and Ingle’s Markets (IMKTA)  have the least to lose.

stock market indicators: EnLink Midstream Partners, LP(ENLK)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    EnLink Midstream Partners (ENLK) is sponsored by independent oil and gas exploration giant Devon Energy (DVN), the owner of this acreage.

    These basins offer superior economics and EnLink’s close relationship with Devon provides leveraged exposure to the upstream operator’s accelerating activity in these plays.

gold stock market

What happened

Shares of Avid Technology(NASDAQ:AVID) rose 20.3% in April 2017, according to data from S&P Global Market Intelligence.

So what

Last month’s share price surge rested on Avid’s release of a coherent cloud-based media production suite. The new version of Avid’s MediaCentral platform takes advantage of the cloud, central storage, and back-end data processing in a way older versions never attempted, modernizing the media production tool in a big way.

“With staggering increases in content consumption and exponential growth in distribution platforms, technology budgets have not kept pace, creating relentless pressure for operational efficiency,” said Avid CEO Louis Hernandez. “To help media organizations meet these challenges head on, we’re extending the Avid MediaCentral Platform and many of our industry-leading tools into the cloud.”

Image source: Getty Images.

gold stock market: CF Industries Holdings, Inc.(CF)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    Agri-Input Companies — Seeds/ Fertilizers/Pesticides Manufacturers

    Monsanto Company (NYSE: MON): +68.82 percent since 2011. Syngenta AG (ADR) (NYSE: SYT): +56.26 percent since 2011. Mosaic Co (NYSE: MOS): -63.1 percent since 2011. Potash Corporation of Saskatchewan (USA) (NYSE: POT): -67.8 percent since 2011. CF Industries Holdings, Inc. (NYSE: CF): +5.04 percent since 2011. Agrium Inc. (USA) (NYSE: AGU): +1.10 percent since 2011.

    Agri-Finance Companies

  • [By Ben Levisohn]

    CF Industries (CF) rose to the top of the S&P 500 today, continuing strength that began earlier this month.

    Getty Images

    CF Industries gained 6.9% to $28.96 today, while the S&P 500 fell 0.2% to 2,181.90. CF Industries has gained 21% in November.

    Despite the rally, CF Industries is still down 29% this year, and as recently as Nov.3, Citigroup’s P.J. Juvekar and team were writing that the fertilizer company was “looking more like a 2008 story” after weaker-than-expected earnings. Donald Trump’s election victory, however, has jumpstarted CF Industries and prompted FBN technical analystJC OHara to list it among the top-50 stocks following Trump’s election, noting that “we want to own the stocks that were first to leave the gate…New Momentum should continue.” On Nov. 9, Barron’s Michael Kahn agreed, writing that “CF Industries does merit a look.”

    CF Industries reported net income of $700 million on sales of $4.3 billion in 2015. Its market capitalization rose to $6.8 billion today from $6.3 billion yesterday.

     

  • [By Ben Levisohn]

    CF Industries Holdings (CF) has climbed 3.3% to $30.25 after getting upgraded to Buy from Neutral at Goldman Sachs.

    Nektar Therapeutics (NKTR) has soared 21% to $18.80 after positive results from a pain-killer trial.

gold stock market: Immersion Corporation(IMMR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Immersion Corporation (NASDAQ: IMMR) shares were also up, gaining 22 percent to $7.29. Immersion disclosed that Vic Viegas has agreed to resign as CEO and as a director. The company named Carl Schlachte as Interim CEO.

  • [By Lisa Levin]

    Immersion Corporation (NASDAQ: IMMR) shares were also up, gaining 20 percent to $7.18. Immersion disclosed that Vic Viegas has agreed to resign as CEO and as a director. The company named Carl Schlachte as Interim CEO.

  • [By Jim Robertson]

    On Thursday, our Under the Radar Movers newsletter suggested shorting small cap technology stock Immersion Corporation (NASDAQ: IMMR):

    We love how well developed the selling of Immersion shares has been. Rather than a sharp, v-shaped reversal — which may or may not follow through — we’ve seen a bowl-shaped transition from an uptrend to a downtrend. This ups the odds of downside follow-through, as there’s been no price “shock” to invite a sudden wave of buying.

gold stock market: The Kraft Heinz Company(KHC)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    The 325,442,152 shares Berkshire owns of Kraft Heinz Co. (NASDAQ: KHC) are carried onthe balance sheet at a GAAP figure of $15.3 billion and had a year-end market value of $28.4 billion. The cost basis for the shares is $9.8 billion.

  • [By Daniel Sparks]

    Shares of consumer-products company Colgate-Palmolive (NYSE:CL) increased as much as 7.4% on Wednesday on speculation thatKraft Heinz (NASDAQ:KHC)could acquire the company. Colgate stock finished the trading day up about 5.7%.

  • [By Ben Levisohn]

    Susquehanna’s Pablo Zuanic and team note that Keurig’s business in K-cups has been slowing ever since it was bought by JAB, a problem that could be solved in a very convoluted way by a Mondelez International (MDLZ)-Kraft Heinz (KHC) merger. They explain:

gold stock market: Chiasma, Inc.(CHMA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Chiasma Inc (NASDAQ: CHMA) was down, falling around 13 percent to $9.51 ahead of the U.S. Food and Drug Administration’s decision on Friday to approve or reject the company’s therapy. The status of its oral treatment for acromegaly, a capsule known as Mycapssa, will be in focus on Friday. The Street’s biotechnology expert Adam Feuerstein stated that an investor source believes the FDA will reject Chiasma’s capsules because data from a single-arm study failed to demonstrate a clinically meaningful benefit among patients.

financial markets

June 22, 2017: Here are four stocks trading with heavy volume among 106 equities making new 52-week lows in Thursday’s session. On the NYSE, advancers led decliners by nearly 3 to 2 and on the Nasdaq, advancers led decliners by about the same ratio.

The Hain Celestial Group Inc. (NASDAQ: HAIN) posted a new 52-week low of $31.70 on Thursday, down about 4.4% compared with Wednesday’s closing price of $33.16. The stock’s 52-week high is $56.99. Volume totaled more than 12.5 million shares, about 10 times the daily average of around 1.2 million. The organic food company said this morning that an accounting review has shown that the company does not need to change its accounting practices. Shares turned positive later in the day and are on track to close up about 1%.

DDR Corp. (NYSE: DDR) dropped about 3.2% Thursday to post a new 52-week low of $8.11 after closing at $8.38 on Wednesday. The stock’s 52-week high is $19.92. Volume of nearly 12 million was about 40% higher than the daily average. The company had no specific news.

financial markets: The Michaels Companies, Inc.(MIK)

Advisors’ Opinion:

  • [By Laurie Kulikowski]

    We rate MICHAELS COS INC as a Sell with a ratings score of D+. This is driven by some concerns, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. Among the areas we feel are negative, one of the most important has been weak operating cash flow. 

  • [By Jim Cramer]

    After a year of stock price fluctuations, the net result is that MIK’s price has not changed very much. Although its weak earnings growth may have played a role in this flat result, don’t lose sight of the fact that the performance of the overall market, as measured by the S&P 500 Index, was essentially similar. Turning toward the future, the fact that the stock has come down in price over the past year should not necessarily be interpreted as a negative; it could be one of the factors that may help make the stock attractive down the road. Right now, however, we believe that it is too soon to buy.

     

  • [By Jim Cramer]

    The company, on the basis of net income growth from the same quarter one year ago, has significantly outperformed against the S&P 500 and exceeded that of the Specialty Retail industry average. The net income increased by 20.0% when compared to the same quarter one year prior, going from $64.00 million to $76.80 million.

     

  • [By WWW.THESTREET.COM]

    Earnings of note in the coming week include Analogic (ALOG) and Ascena Retail (ASNA) on Monday; Bojangles (BOJA) , H&R Block (HRB) , and Dick’s Sporting Goods (DKS) , Michaels (MIK) , and Urban Outfitters (URBN) on Tuesday; Ciena (CIEN) , Bankrate (RATE) , Express (EXPR) , Vera Bradley (VRA) , and Bob Evans Farms (BOBE) on Wednesday; El Pollo Loco (LOCO) , Hugo Boss (BOSSY) , Party City (PRTY) , Signet Jewelers (SIG) , and Verifone Systems (PAY) on Thursday; and Kirkland’s (KIRK) , and Vail Resorts (MTN) on Friday.

  • [By JPMorgan]

    MIK’s results over the past year point to the company’s success in improving merchandising, marketing, and in-store execution plus the benefits of having a functioning e-commerce website. We believe part of the challenge for the bears is both a lack of appreciation for the category as well as missing the historical context of how leadership has evolved. Indeed, the difference in focus on "the front end" under CEO Chuck Rubin (who arrived in 2013) vs. a more process-oriented and margin-focused CEO prior to his arrival left a lot of impactful, low hanging fruit opportunities. Finally, while we acknowledge that longer term the sustainable comp is lower than the recent ~4% underlying trend, we point to the low volatility of sales, high cash generative nature of the business, barriers to entry (e.g., high SKU density, low inventory turns, lack of brands), and MIK’s market leadership as reasons why the multiple has the potential to expand over time (a la AZO). Balance sheet de-levering should also make the PE look increasingly cheap over time and transfer cash/value to equity holders. 

  • [By Jim Cramer]

    42.37% is the gross profit margin for MICHAELS COS INC which we consider to be strong. Regardless of MIK’s high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, the net profit margin of 6.57% trails the industry average.

    MICHAELS COS INC has improved earnings per share by 19.4% in the most recent quarter compared to the same quarter a year ago. This year, the market expects an improvement in earnings ($1.70 versus $1.04).

     

financial markets: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By Lisa Levin]

    SAGE Therapeutics Inc (NASDAQ: SAGE) shares shot up 73 percent to $159.39 after the company disclosed that Phase 2 trial of SAGE-217 met its primary endpoint.

  • [By WWW.THESTREET.COM]

    Position: Long GLD small, bonds, SDS; short TLT small, SPY small .

  • [By Chris Lange]

    Shares of Sage Therapeutics Inc. (NASDAQ: SAGE) saw an incredible gain on Thursday after the firm announced positive top-line results from its midstage trial. Specifically, the firm reported results from its Phase 2 trial of Sage-217 for the treatment of moderate to severe major depressive disorder (MDD).

  • [By WWW.THESTREET.COM]

    The Good

    The market remains resistant (Rs over Ss and Ns). Brokerages, banks and insurance companies continue their league-leading strength. The Russell 2000 Index is up for the 15th consecutive day. Retail extends yesterday’s strength. Nordstrom (JWN) , Macy’s (M) , Best Buy (BBY) , Target (TGT) , Walmart (WMT) , Foot Locker (FL) and JCPenney (JCP) are strong. First day down for Amazon (AMZN) . Agricultural commodities are lackluster, but soybeans are up another up $0.05 today, up substantially for three days in a row. Speculative biotech (Sage (SAGE) , FibroGen (FGEN) , Acadia Pharmaceuticals (ACAD) and Aerie Pharmaceuticals  (AERI) ) stronger after recent weakness. Ag equipment up big time after the Deere (DE) beat.

    The Bad

financial markets: WildHorse Resource Development Corporation (WRD)

Advisors’ Opinion:

  • [By Paul Ausick]

    WildHorse Resource Development Corp. (NYSE: WRD) raised $413 million on the sale of $27.5 million at $15 per share, well below the expected range of $19 to $21. Shares popped just 0.4% for the day and closed the week down 0.9%.

financial markets: VEXIM EUR0.10 (VXMFF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    French medical device maker Vexim (OTC:VXMFF) contracted with an unnamed China lab to begin China registration studies for its vertebral fracture repair device, SpineJack庐. Vexim recently was granted patents for the device in China and Japan. SpineJack is an implant designed to repair a fractured vertebra and restore spinal cord balance. The 30 minute procedure is useful in 95% of vertebral fractures, according to Vexim. SpineJack was CE marked for EU use in 2010 and now is indicated for trauma and other vertebral fractures.

financial markets: Xcel Energy Inc.(XEL)

Advisors’ Opinion:

  • [By Shauna O’Brien]

    Jefferies announced on Wednesday that it has raised its rating on Xcel Energy Inc (XEL).

    The firm has upgraded XEL from “Hold” to “Buy,” and has raised the company’s price target from $31 to $32.50. This new price target suggests a 15% upside from the stock’s current price of $27.72.

    Analyst Paul B. Fremont commented: “The stock is currently trading at an 8% P/E discount to our 2015E group average multiple.”

    “Despite a difficult political environment in Minnesota the company was able to achieve a reasonable outcome in its NSP-Minnesota rate case,” the analyst added.

    Looking forward, the firm has increased its FY2014 outlook from $1.95 to $2.00 per share.

    Xcel Energy shares were mostly flat during pre-market trading Wednesday. The stock has been mostly flat YTD.

financial markets: Chiasma, Inc.(CHMA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Chiasma Inc (NASDAQ: CHMA) was down, falling around 13 percent to $9.51 ahead of the U.S. Food and Drug Administration’s decision on Friday to approve or reject the company’s therapy. The status of its oral treatment for acromegaly, a capsule known as Mycapssa, will be in focus on Friday. The Street’s biotechnology expert Adam Feuerstein stated that an investor source believes the FDA will reject Chiasma’s capsules because data from a single-arm study failed to demonstrate a clinically meaningful benefit among patients.

Best Casino Stocks To Own Right Now

More than two years after a government crackdown on corruption sent Macau gaming stocks tumbling, The Chinese government has unveiled yet another new regulation on the Macau gaming industry that has hit gaming stocks hard. The latest new law cut the daily ATM withdrawal limit in Macau from 10,000 patacas to 5,000 patacas, or roughly $626.

Unfortunately, transparency and predictability has never been one of the Chinese government’s strong points. Wynn Resorts, Limited (NASDAQ: WYNN) CEO Steve Wynn said the government’s behavior was “preposterous” when it kept operators in the dark about how many table games they would be allotted just weeks prior to opening billion-dollar new resorts. For the record, none of the major operators that have opened resorts in the past two years have received the table allotment they requested.

Although the U.S. gaming market likely doesn’t have the kind of long-term growth potential that Macau does, U.S. casinos are doing just fine these days. In the current fiscal year, Las Vegas Strip revenue is trending about 6% ahead of last year, and other regions of the country are doing even better. For better or worse, U.S. stock investors likely won’t have to worry about new regulations in the next four years under President-elect Trump.

Best Casino Stocks To Own Right Now: American Capital, Ltd.(ACAS)

Advisors’ Opinion:

  • [By Monica Gerson]

    American Capital Ltd. (NASDAQ: ACAS) shares rose 5.63 percent to $16.50 in the pre-market trading session as Ares Capital Corporation (NASDAQ: ARCC) reported the purchase of American Capital at $3.4 billion in cash and stock.

Best Casino Stocks To Own Right Now: Marvell Technology Group Ltd.(MRVL)

Advisors’ Opinion:

  • [By Chris Neiger]

    Specifically, GoPro (NASDAQ:GPRO) and Marvell Technology (NASDAQ:MRVL) caught my eye recently. The two companies are hardly pure-plays in the IoT (there aren’t many of those), but each is betting on the Internet of Things in its own way, and each looks a bit overpriced right now.

  • [By Lisa Levin]

    Marvell Technology Group Ltd. (NASDAQ: MRVL) agreed to acquire Cavium Inc (NASDAQ: CAVM) in a deal valued at around $6 billion.

    Under the deal, Marvell will buy Cavium for $40 per share in cash and 2.1757 shares of its stock for each Cavium share.

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Friday’s regular session.

  • [By Peter Graham]

    The Q4 2017 earnings report for mid cap fabless semiconductor stock Marvell Technology Group Ltd (NASDAQ: MRVL) is scheduled forafter the marketcloses onThursday (March 2nd). Marvell Technology Groupwas in our SmallCap Network Elite Opportunity (SCN EO) portfolio back in 2013 becauseits fundamental and technical context appeared very attractive at the time and the Company’s products also drive Samsung’s family of mobile devices. Our SCN EO newsletter had noted back in May 2013:

  • [By Lisa Levin]

    Marvell Technology Group Ltd. (NASDAQ: MRVL) agreed to acquire Cavium Inc (NASDAQ: CAVM) in a deal valued at around $6 billion.

    Under the deal, Marvell will buy Cavium for $40 per share in cash and 2.1757 shares of its stock for each Cavium share.

  • [By Peter Graham]

    Mid cap fabless semiconductor stock Marvell Technology Group Ltd (NASDAQ: MRVL) reported Q2 fiscal 2018 earnings after the Thursday market close with results beating Wall Street expectations. Q2 revenue was $604.750 million (which exceeded the midpoint of the Company’s guidance provided on May 25, 2017) versus $597.346 million. GAAP net income from continuing operations was $165.259 million versus $51.305 million. The CEO commented:

Best Casino Stocks To Own Right Now: Chiasma, Inc.(CHMA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Chiasma Inc (NASDAQ: CHMA) was down, falling around 13 percent to $9.51 ahead of the U.S. Food and Drug Administration’s decision on Friday to approve or reject the company’s therapy. The status of its oral treatment for acromegaly, a capsule known as Mycapssa, will be in focus on Friday. The Street’s biotechnology expert Adam Feuerstein stated that an investor source believes the FDA will reject Chiasma’s capsules because data from a single-arm study failed to demonstrate a clinically meaningful benefit among patients.